Cardiovascular

Driving success in cardiology trials from early phase to post-approval

Advance your cardiology drug or device development with a team focused on the right sites and the best outcomes for patients.

Partner with cardiologists, project managers and strategists with deep drug discovery and clinical development experience.

Incorporate a rigorous approach to study design development and endpoint selection with significant expertise in the use of imaging, in vitro and digital endpoints.

Serving as your partner for comprehensive cardiology clinical trials.

Whether you need support with early phase adaptive trial design, site selection, patient identification or targeted services for late-phase outcomes trials, you can trust the expertise of an agile and experienced partner.

Fortrea’s dedicated, global cardiovascular team—backed by industry leaders in medical, operational, and strategy—serves as a committed partner with the expertise and experience to deliver a comprehensive trial solution that fits your organization’s business and strategy. Together, let’s bring novel cardiovascular therapies to market and help deliver breakthroughs that change lives.

Experience matters when choosing a partner

Let's Connect

We’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers as we’ve advanced their cardiovascular programs. In the last 5 years, we have supported:

375+

Cardiology Studies

9,720+

Sites

146,500+

Patients

Top Indications

Atherosclerotic cardiovascular disease (ASCVD)
Heart failure and cardiomyopathies
Hyperlipidemia
Acute coronary syndromes
Cardiovascular devices

Get the latest updates from our cardiovascular team

We’re sharing our latest news, events and publications.

White Paper

Cardiovascular outcome trials: strategic insights for country and site distribution

Read the white paper

White Paper

Cardio-metabolic rare diseases: strategic insights for country and site distibution

Read the white paper

Article

Promoting access to innovative cardiac medical devices through diversity and inclusion

Read the article

Expect full support for your cardiology trial

Beyond our novel solutions, industry-leading processes, and subject matter expertise for your cardiovascular trial, we can offer our:

Recent and relevant experience in a large portfolio of CV trials from
early phase to registrational and post-approval.
Extensive ongoing site relationships along with our Xcellerate® trial data with extensive central laboratory data* and other data sources to enhance site selection and maximize patient recruitment. (*Fortrea will maintain exclusive CRO access to the Labcorp data that supports its clinical-enabling solutions for a fixed period of time)
Close collaboration with core labs to train and qualify sites in your necessary imaging and protocol procedures.
Endpoint “fast track strategies” and adjudication that result in more robust data for DMC/DSMB safety reviews—and no delays to database lock.

Meet the team

Cheerag Shirodaria, MD Vice President

Ines Pagel-Langenickel, MD Executive Medical Director

Meet the team

Your needs. Our solutions.

As a provider of comprehensive Phase I through IV clinical trial management, clinical pharmacology, patient access solutions and other enabling services, Fortrea partners with emerging and large biopharma and medical device and diagnostic companies to drive healthcare innovation throughout the world.